Cover Image
Market Research Report

Asia Pacific Stem Cell Assay Market Forecast 2019-2027

Published by Inkwood Research Product code 484186
Published Content info 84 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Stem Cell Assay Market Forecast 2019-2027
Published: March 9, 2019 Content info: 84 Pages
Description

KEY FINDINGS

The Asia Pacific market for the stem cell assay market is anticipated to grow $XX million by 2027 from $ XX million in 2018. During the forecast period, the growth of the market is presumed at CAGR of 19.08%. The base year considered for the market study is 2018. Rise in the adoption of stem cell assay, the evolvement of technology and increase spending in the stem cell assay market are the key drivers in the Asia Pacific stem cell assay market.

MARKET INSIGHTS

India, China, Japan, Australia, South Korea and the Rest of Asia Pacific are considered for the market analysis. The Asia Pacific stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user, and geography. The Asia Pacific stem cell assay market by type is segmented into cell viability and toxicity assays, isolation and purification assays, cell identification assays, cell differentiation assays, cell function assays, and cell apoptosis assays. The product of Asia Pacific stem cell assay market is segmented into instruments and detection kits. The kits of stem cell assay market are further segmented into adult stem cell kits, human embryonic stem cell kit. The stem cell market by application is further bifurcated into regenerative medicine and therapy development, drug discovery and development and clinical research market. The end-user of the stem cell market is segmented into research institutes and industry research.

Increasing Adoption of Stem Cell Assay, improvement in the Technology, high expense in Stem Cell Research are the major drivers for the market growth in the Asia Pacific region. The rise in the adoption of stem cell assay for drug screening & testing is one of the major reasons driving industry research.

COMPETITIVE INSIGHTS

The major companies that are mentioned in stem cell assay market of Asia Pacific are Takara Holdings Inc., Cell Bio Labs, Inc., Hemogenix Inc., Corning Inc., Fibrocell Science Inc., Thermo Fisher, Becton Dickinson, Stem Cell Technologies, Promega Corporation, GE Healthcare, R&D Systems, Merck Millipore (holding company is Merck KGaA), Bio-Rad, Stryker Corporation, and Cellular Dynamics International (Holding Company Fujifilm).

Table of Contents
Product Code: 4709

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. INDUSTRY RESEARCH IS THE LEADING END-USER SEGMENT
    • 3.2.2. INCREASING DEMAND FOR REGENERATIVE MEDICINE
    • 3.2.3. CELL VIABILITY & TOXICITY ASSAYS ARE MAJORLY USED
    • 3.2.4. ADULT STEM CELL KITS ARE THE FASTEST GROWING STEM CELL KIT

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISING ADOPTION OF STEM CELL ASSAY
    • 4.2.2. TECHNOLOGICAL ADVANCEMENT
    • 4.2.3. GROWING SPENDING IN STEM CELL RESEARCH
    • 4.2.4. POTENTIAL OF STEM CELLS IN REGENERATIVE MEDICINE
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST FOR TREATMENT
    • 4.3.2. SLOW RESPONSE TIME OF REGULATORY BODIES
    • 4.3.3. ETHICAL CONCERN RELATED TO STEM CELL RESEARCH
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. CHANGING MARKET DYNAMICS
    • 4.4.2. EMERGING APPLICATION AS A DRUG DISCOVERY TOOL
  • 4.5. MARKET CHALLENGES
    • 4.5.1. ISSUE RELATED TO THE PATIENT'S IMMUNE SYSTEM
    • 4.5.2. STRINGENT GOVERNMENT REGULATIONS

5. MARKET BY TYPE OF ASSAY

  • 5.1. CELL VIABILITY & TOXICITY ASSAYS
  • 5.2. ISOLATION/PURIFICATION ASSAYS
  • 5.3. CELL IDENTIFICATION ASSAYS
  • 5.4. CELL DIFFERENTIATION ASSAYS
  • 5.5. CELL FUNCTION ASSAYS
  • 5.6. CELL APOPTOSIS ASSAYS

6. MARKET BY PRODUCT

  • 6.1. INSTRUMENTS
  • 6.2. DETECTION KIT

7. MARKET BY KITS

  • 7.1. ADULT STEM CELL KIT
  • 7.2. HUMAN EMBRYONIC STEM CELL KIT

8. MARKET BY APPLICATION

  • 8.1. REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET
  • 8.2. DRUG DISCOVERY & DEVELOPMENT MARKET
  • 8.3. CLINICAL RESEARCH

9. MARKET BY END-USER

  • 9.1. RESEARCH INSTITUTES
  • 9.2. INDUSTRY RESEARCH

10. KEY ANALYTICS

  • 10.1. PORTER'S FIVE FORCE MODEL
    • 10.1.1. THREAT OF NEW ENTRANTS
    • 10.1.2. THREAT OF SUBSTITUTE
    • 10.1.3. BARGAINING POWER OF BUYER
    • 10.1.4. BARGAINING POWER OF SUPPLIER
    • 10.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 10.2. KEY BUYING CRITERIA
    • 10.2.1. PRICING
    • 10.2.2. EFFICACY
    • 10.2.3. ACCURACY
  • 10.3. VALUE CHAIN ANALYSIS
  • 10.4. PEST ANALYSIS
  • 10.5. PATENT ANALYSIS
    • 10.5.1. ASIA PACIFIC PATENT ANALYSIS
  • 10.6. REGULATORY FRAMEWORK
  • 10.7. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS

  • 11.1. ASIA-PACIFIC
    • 11.1.1. INDIA
    • 11.1.2. CHINA
    • 11.1.3. JAPAN
    • 11.1.4. SOUTH KOREA
    • 11.1.5. AUSTRALIA
    • 11.1.6. REST OF ASIA-PACIFIC

12. COMPETITIVE LANDSCAPE

    • 12.1.1. MARKET SHARE ANALYSIS
  • 12.2. COMPANY PROFILES
    • 12.2.1. BECTON DICKINSON
      • 12.2.1.1. COMPANY OVERVIEW
      • 12.2.1.2. PRODUCT PORTFOLIO
      • 12.2.1.3. SCOT ANALYSIS
      • 12.2.1.4. STRATEGIC INITIATIVES
    • 12.2.2. BIO-RAD
      • 12.2.2.1. COMPANY OVERVIEW
      • 12.2.2.2. PRODUCT PORTFOLIO
      • 12.2.2.3. SCOT ANALYSIS
      • 12.2.2.4. STRATEGIC INITIATIVES
    • 12.2.3. CELL BIO LABS, INC.
      • 12.2.3.1. COMPANY OVERVIEW
      • 12.2.3.2. PRODUCT PORTFOLIO
      • 12.2.3.3. SCOT ANALYSIS
    • 12.2.4. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
      • 12.2.4.1. COMPANY OVERVIEW
      • 12.2.4.2. PRODUCT PORTFOLIO
      • 12.2.4.3. SCOT ANALYSIS
      • 12.2.4.4. STRATEGIC INITIATIVES
    • 12.2.5. CORNING INC.
      • 12.2.5.1. COMPANY OVERVIEW
      • 12.2.5.2. PRODUCT PORTFOLIO
      • 12.2.5.3. SCOT ANALYSIS
      • 12.2.5.4. STRATEGIC INITIATIVES
    • 12.2.6. FIBROCELL SCIENCE INC.
      • 12.2.6.1. COMPANY OVERVIEW
      • 12.2.6.2. PRODUCT PORTFOLIO
      • 12.2.6.3. SCOT ANALYSIS
      • 12.2.6.4. STRATEGIC INITIATIVES
    • 12.2.7. GE HEALTHCARE
      • 12.2.7.1. COMPANY OVERVIEW
      • 12.2.7.2. PRODUCT PORTFOLIO
      • 12.2.7.3. SCOT ANALYSIS
      • 12.2.7.4. STRATEGIC INITIATIVES
    • 12.2.8. HEMOGENIX INC.
      • 12.2.8.1. COMPANY OVERVIEW
      • 12.2.8.2. PRODUCT PORTFOLIO
      • 12.2.8.3. SCOT ANALYSIS
    • 12.2.9. MERCK MILLIPORE (HOLDING COMPANY IS MERCK KGAA)
      • 12.2.9.1. COMPANY OVERVIEW
      • 12.2.9.2. PRODUCT PORTFOLIO
      • 12.2.9.3. SCOT ANALYSIS
      • 12.2.9.4. STRATEGIC INITIATIVES
    • 12.2.10. PROMEGA CORPORATION
      • 12.2.10.1. COMPANY OVERVIEW
      • 12.2.10.2. PRODUCTS PORTFOLIO
      • 12.2.10.3. SCOT ANALYSIS
      • 12.2.10.4. STRATEGIC INITIATIVES
    • 12.2.11. R&D SYSTEMS
      • 12.2.11.1. COMPANY OVERVIEW
      • 12.2.11.2. PRODUCT PORTFOLIO
      • 12.2.11.3. SCOT ANALYSIS
    • 12.2.12. STEM CELL TECHNOLOGIES
      • 12.2.12.1. COMPANY OVERVIEW
      • 12.2.12.2. PRODUCT PORTFOLIO
      • 12.2.12.3. SCOT ANALYSIS
      • 12.2.12.4. STRATEGIC INITIATIVES
    • 12.2.13. STRYKER CORPORATION
      • 12.2.13.1. COMPANY OVERVIEW
      • 12.2.13.2. PRODUCT PORTFOLIO
      • 12.2.13.3. SCOT ANALYSIS
      • 12.2.13.4. STRATEGIC INITIATIVES
    • 12.2.14. TAKARA HOLDINGS INC.
      • 12.2.14.1. COMPANY OVERVIEW
      • 12.2.14.2. PRODUCT PORTFOLIO
      • 12.2.14.3. SCOT ANALYSIS
      • 12.2.14.4. STRATEGIC INITIATIVES
    • 12.2.15. THERMO FISHER
      • 12.2.15.1. COMPANY OVERVIEW
      • 12.2.15.2. PRODUCT PORTFOLIO
      • 12.2.15.3. SCOT ANALYSIS
      • 12.2.15.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 ASIA PACIFIC STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • TABLE 2 ASIA PACIFIC STEM CELL ASSAY MARKET BY TYPE OF ASSAY 2019-2027 ($ MILLION)
  • TABLE 3 ASIA PACIFIC CELL VIABILITY & TOXICITY ASSAYS MARKET 2019-2027 ($ MILLION)
  • TABLE 4 ASIA PACIFIC ISOLATION/PURIFICATION ASSAYS MARKET 2019-2027 ($ MILLION)
  • TABLE 5 ASIA PACIFIC CELL IDENTIFICATION ASSAYS MARKET 2019-2027 ($ MILLION)
  • TABLE 6 ASIA PACIFIC CELL DIFFERENTIATION ASSAYS MARKET 2019-2027 ($ MILLION)
  • TABLE 7 ASIA PACIFIC CELL FUNCTION ASSAYS MARKET 2019-2027 ($ MILLION)
  • TABLE 8 ASIA PACIFIC CELL APOPTOSIS ASSAYS MARKET 2019-2027 ($ MILLION)
  • TABLE 9 ASIA PACIFIC STEM CELL ASSAY MARKET BY PRODUCT 2019-2027 ($ MILLION)
  • TABLE 10 ASIA PACIFIC INSTRUMENTS MARKET 2019-2027 ($ MILLION)
  • TABLE 11 ASIA PACIFIC DETECTION KIT MARKET 2019-2027 ($ MILLION)
  • TABLE 12 ASIA PACIFIC STEM CELL ASSAY MARKET BY KITS 2019-2027 ($ MILLION)
  • TABLE 13 ASIA PACIFIC ADULT STEM CELL KIT MARKET 2019-2027 ($ MILLION)
  • TABLE 14 ASIA PACIFIC HUMAN EMBRYONIC STEM CELL KIT MARKET 2019-2027 ($ MILLION)
  • TABLE 15 ASIA PACIFIC STEM CELL ASSAY MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 16 ASIA PACIFIC REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET 2019-2027 ($ MILLION)
  • TABLE 17 ASIA PACIFIC DRUG DISCOVERY & DEVELOPMENT MARKET 2019-2027 ($ MILLION)
  • TABLE 18 ASIA PACIFIC CLINICAL RESEARCH 2019-2027 ($ MILLION)
  • TABLE 19 ASIA PACIFIC STEM CELL ASSAY MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 20 ASIA PACIFIC RESEARCH INSTITUTES MARKET 2019-2027 ($ MILLION)
  • TABLE 21 RESEARCH ACTIVITIES ON DEIFFERENT TYPE OS STEM CELLS
  • TABLE 22 ASIA PACIFIC INDUSTRY RESEARCH MARKET 2019-2027 ($ MILLION)
  • TABLE 23 ASIA-PACIFIC STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 24 STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES

FIGURES LIST

  • FIGURE 1 ASIA PACIFIC STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 ASIA PACIFIC STEM CELL ASSAY MARKET SHARE BY TYPE OF ASSAY 2018 & 2027 (%)
  • FIGURE 3 ASIA PACIFIC STEM CELL ASSAY MARKET BY CELL VIABILITY & TOXICITY ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 4 ASIA PACIFIC STEM CELL ASSAY MARKET BY ISOLATION/PURIFICATION ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 5 ASIA PACIFIC STEM CELL ASSAY MARKET BY CELL IDENTIFICATION ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 6 ASIA PACIFIC STEM CELL ASSAY MARKET BY CELL DIFFERENTIATION ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 7 ASIA PACIFIC STEM CELL ASSAY MARKET BY CELL FUNCTION ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 8 ASIA PACIFIC STEM CELL ASSAY MARKET BY CELL APOPTOSIS ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 9 ASIA PACIFIC STEM CELL ASSAY MARKET SHARE BY PRODUCT 2018 & 2027 (%)
  • FIGURE 10 ASIA PACIFIC STEM CELL ASSAY MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)
  • FIGURE 11 ASIA PACIFIC STEM CELL ASSAY MARKET BY DETECTION KIT 2019-2027 ($ MILLION)
  • FIGURE 12 ASIA PACIFIC STEM CELL ASSAY MARKET SHARE BY TYPE OF ASSAY 2018 & 2027 (%)
  • FIGURE 13 ASIA PACIFIC STEM CELL ASSAY MARKET BY ADULT STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 14 ASIA PACIFIC STEM CELL ASSAY MARKET BY HUMAN EMBRYONIC STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 15 ASIA PACIFIC STEM CELL ASSAY MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 16 ASIA PACIFIC STEM CELL ASSAY MARKET BY REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET 2019-2027 ($ MILLION)
  • FIGURE 17 ASIA PACIFIC STEM CELL ASSAY MARKET BY DRUG DISCOVERY & DEVELOPMENT MARKET 2019-2027 ($ MILLION)
  • FIGURE 18 ASIA PACIFIC STEM CELL ASSAY MARKET BY CLINICAL RESEARCH 2019-2027 ($ MILLION)
  • FIGURE 19 ASIA PACIFIC STEM CELL ASSAY MARKET SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 20 ASIA PACIFIC STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES MARKET 2019-2027 ($ MILLION)
  • FIGURE 21 ASIA PACIFIC STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH MARKET 2019-2027 ($ MILLION)
  • FIGURE 22 PORTER'S FIVE FORCE MODEL
  • FIGURE 23 ASIA PACIFIC STEM CELL ASSAY MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 24 INDIA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 25 CHINA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 26 JAPAN STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 27 SOUTH KOREA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 28 AUSTRALIA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 REST OF ASIA-PACIFIC STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 STEM CELL ASSAY MARKET SHARE ANALYSIS OF KEY PLAYERS 2018 (%)
Back to Top